Imaging software developer Cedara Software, a division of Merge Technologies of Milwaukee, announced that the breast computer-aided detection (CAD) system, Cedara B-CAD, has received Food and Drug Administration 510(k) clearance. The system is designed to help radiologists analyze breast ultrasound images through automated segmentation, characterization, classification, annotation, and report generation.
Cedara B-CAD was developed by Toronto-based Medipattern, a company specializing in medical pattern recognition, and is being marketed by Cedara through its technology partnership program. Breast ultrasound is particularly useful for evaluating palpable masses in young (under 30), pregnant, or lactating women, among others, according to the company.
Cedara B-CAD will soon be commercially available in the U.S., the company said.
By AuntMinnie.com staff writers
June 2, 2005
Related Reading
Merge eFilm, Cedara close deal, June 1, 2005
Court approves Cedara merger with Merge, May 27, 2005
Merge shareholders approve Cedara merger, May 25, 2005
Cedara posts record Q3, April 28, 2005
Analogic divests Cedara stake, February 18, 2005
Copyright © 2005 AuntMinnie.com
![Examples of ultrasound findings and techniques. (A) Images in a 39-year-old male patient with a mass in the left thigh. The mass is heterogeneous on the B-mode US image (compared with the patient in D) and showed increased microvascularity (superb microvascular imaging [SMI]) and shear-wave elastography (SWE) values. Undifferentiated pleomorphic sarcoma was diagnosed at biopsy (with pleomorphic rhabdomyosarcoma in surgical specimen). (B) Images in an 18-year-old male patient with a mass in the left leg. The mass is hypoechoic on the B-mode image, with no other findings suggestive of malignancy. The lesion is in contact with the cortex of the tibia, which is slightly irregular. CT revealed a doubtful anteromedial tibial erosion. The microvascular study demonstrated high vascularization, suggestive of malignancy. Periosteal Ewing sarcoma was diagnosed with both histologic and immunohistochemical confirmation. (C) Images in a 69-year-old female patient with a lump growing on the outside of the left leg. Multiple SWE examinations were performed (please note the high values obtained in the measurements, whereas the color map highlights the stiffness relative to adjacent tissues). SMI showed areas of increased vascularization to target for sampling. Undifferentiated spindle cell sarcoma was diagnosed at biopsy, with residual leiomyosarcoma in the surgical specimen after neoadjuvant therapy. (D) Images in a 56-year-old female patient with a mass in the right thigh. The mass is heterogeneous at both B-mode ultrasound (similar to patient A) and MRI (coronal T2-weighted spectral attenuated inversion recovery [SPAIR]; T1-weighted pre-contrast and postcontrast imaging), which even shows uptake after the administration of paramagnetic contrast material, which is traditionally suggestive of malignancy. Low values at SMI and elastography are suggestive of benignity. Spindle cell lipoma was diagnosed at biopsy, with atypical spindle cell lipomatous tumor in the surgical specimen.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/08/images-radiol250278fig2.APCFLSvX6p.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
